恩(en)威醫藥9月(yue)(yue)(yue)21日(ri)公(gong)告，本(ben)次解除(chu)限(xian)售(shou)(shou)并上(shang)市流通的(de)限(xian)售(shou)(shou)股(gu)(gu)(gu)(gu)份為(wei)公(gong)司(si)首次公(gong)開發(fa)(fa)行前(qian)部分限(xian)售(shou)(shou)股(gu)(gu)(gu)(gu)。本(ben)次解除(chu)限(xian)售(shou)(shou)股(gu)(gu)(gu)(gu)東戶數共計(ji)8戶，解除(chu)限(xian)售(shou)(shou)的(de)股(gu)(gu)(gu)(gu)份數量(liang)為(wei)544.28萬股(gu)(gu)(gu)(gu)，占公(gong)司(si)總(zong)股(gu)(gu)(gu)(gu)本(ben)的(de)7.76%。限(xian)售(shou)(shou)期為(wei)自公(gong)司(si)首次公(gong)開發(fa)(fa)行股(gu)(gu)(gu)(gu)票并上(shang)市之日(ri)起12個月(yue)(yue)(yue)。本(ben)次解除(chu)限(xian)售(shou)(shou)股(gu)(gu)(gu)(gu)份的(de)上(shang)市流通日(ri)期為(wei)2023年9月(yue)(yue)(yue)25日(ri)（星期一）。